Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 2
2020 1
2021 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Multipathogen-specific T cells against viral and fungal infections.
Papadopoulou A, Koukoulias K, Alvanou M, Kouimtzidis A, Athanasiou E, Savvopoulos N, Markantonatou AM, Siotou E, Vyzantiadis TA, Anagnostopoulos A, Yannaki E. Papadopoulou A, et al. Among authors: koukoulias k. Bone Marrow Transplant. 2021 Jun;56(6):1445-1448. doi: 10.1038/s41409-020-01210-9. Epub 2021 Jan 8. Bone Marrow Transplant. 2021. PMID: 33420391 No abstract available.
"Cerberus" T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients.
Koukoulias K, Papayanni PG, Georgakopoulou A, Alvanou M, Laidou S, Kouimtzidis A, Pantazi C, Gkoliou G, Vyzantiadis TA, Spyridonidis A, Makris A, Chatzidimitriou A, Psatha N, Anagnostopoulos A, Yannaki E, Papadopoulou A. Koukoulias K, et al. Front Immunol. 2021 Jan 18;11:608701. doi: 10.3389/fimmu.2020.608701. eCollection 2020. Front Immunol. 2021. PMID: 33537032 Free PMC article.
Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.
Papadopoulou A, Alvanou M, Koukoulias K, Athanasiou E, Lazaridou A, Savvopoulos N, Kaloyannidis P, Markantonatou AM, Vyzantiadis TA, Yiangou M, Anagnostopoulos A, Yannaki E. Papadopoulou A, et al. Among authors: koukoulias k. Bone Marrow Transplant. 2019 Dec;54(12):1963-1972. doi: 10.1038/s41409-019-0501-9. Epub 2019 Mar 13. Bone Marrow Transplant. 2019. PMID: 30867554
Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
Papayanni PG, Chasiotis D, Koukoulias K, Georgakopoulou A, Iatrou A, Gavriilaki E, Giannaki C, Bitzani M, Geka E, Tasioudis P, Chloros D, Fylaktou A, Kioumis I, Triantafyllidou M, Dimou-Besikli S, Karavalakis G, Boutou AK, Siotou E, Anagnostopoulos A, Papadopoulou A, Yannaki E. Papayanni PG, et al. Among authors: koukoulias k. Clin Infect Dis. 2021 Dec 6;73(11):2073-2082. doi: 10.1093/cid/ciab371. Clin Infect Dis. 2021. PMID: 33905481 Free PMC article.
Patient risk stratification and tailored clinical management of post-transplant CMV-, EBV-, and BKV-infections by monitoring virus-specific T-cell immunity.
Papadopoulou A, Koukoulias K, Alvanou M, Papadopoulos VK, Bousiou Z, Kalaitzidou V, Kika FS, Papalexandri A, Mallouri D, Batsis I, Sakellari I, Anagnostopoulos A, Yannaki E. Papadopoulou A, et al. Among authors: koukoulias k. EJHaem. 2021 Jun 1;2(3):428-439. doi: 10.1002/jha2.175. eCollection 2021 Aug. EJHaem. 2021. PMID: 35844677 Free PMC article.
Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.
Papadopoulou A, Alvanou M, Koukoulias K, Athanasiou E, Lazaridou A, Savvopoulos N, Kaloyannidis P, Markantonatou AM, Vyzantiadis TA, Yiangou M, Anagnostopoulos A, Yannaki E. Papadopoulou A, et al. Among authors: koukoulias k. Bone Marrow Transplant. 2019 Dec;54(12):2120. doi: 10.1038/s41409-019-0592-3. Bone Marrow Transplant. 2019. PMID: 31222102
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.
Levva S, Kotoula V, Kostopoulos I, Manousou K, Papadimitriou C, Papadopoulou K, Lakis S, Koukoulias K, Karavasilis V, Pentheroudakis G, Balassi E, Zagouri F, Kaklamanos IG, Pectasides D, Razis E, Aravantinos G, Papakostas P, Bafaloukos D, Rallis G, Gogas H, Fountzilas G. Levva S, et al. Among authors: koukoulias k. Cancer Genomics Proteomics. 2017 May-Jun;14(3):181-195. doi: 10.21873/cgp.20030. Cancer Genomics Proteomics. 2017. PMID: 28446533 Free PMC article.